NPI: 1942623319 · BALTIMORE, MD 21212 · General Practice Physician · NPI assigned 01/21/2014
Authorized official SCHNEIDER, STEPHANIE controls 20+ related entities in our dataset. Read more
| Authorized Official | SCHNEIDER, STEPHANIE (VP) |
| NPI Enumeration Date | 01/21/2014 |
Other providers sharing the same authorized official: SCHNEIDER, STEPHANIE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 682 | $66K |
| 2019 | 2,319 | $204K |
| 2020 | 42,019 | $1.56M |
| 2021 | 201,700 | $10.26M |
| 2022 | 218,672 | $12.86M |
| 2023 | 284,075 | $13.32M |
| 2024 | 150,179 | $10.81M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 191,187 | 168,253 | $18.96M |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 72,101 | 62,746 | $7.87M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 97,978 | 85,286 | $7.79M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 54,337 | 47,002 | $4.38M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 103,372 | 88,867 | $3.09M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 54,760 | 50,127 | $1.64M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 15,030 | 14,457 | $1.53M |
| 99215 | Prolong outpt/office vis | 15,711 | 9,922 | $739K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 75,417 | 55,362 | $738K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 79,703 | 67,535 | $482K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 16,794 | 16,160 | $439K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8,834 | 6,919 | $404K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4,845 | 3,763 | $217K |
| 99205 | Prolong outpt/office vis | 2,504 | 1,951 | $168K |
| 81025 | 26,310 | 21,555 | $108K | |
| 81003 | 43,770 | 36,953 | $107K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2,817 | 1,784 | $71K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,591 | 1,414 | $63K |
| 71046 | Radiologic examination, chest; 2 views | 5,926 | 4,692 | $59K |
| 82962 | 3,602 | 2,432 | $53K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 466 | 461 | $34K |
| 87807 | 7,314 | 6,154 | $33K | |
| 93000 | 2,850 | 2,020 | $20K | |
| 81002 | 1,376 | 1,016 | $14K | |
| 87070 | 1,258 | 947 | $12K | |
| 73562 | 737 | 434 | $8K | |
| 73630 | 983 | 559 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 935 | 600 | $5K |
| 73610 | 897 | 488 | $4K | |
| 73130 | 444 | 232 | $3K | |
| 90715 | 325 | 138 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 894 | 579 | $2K |
| 29125 | 119 | 71 | $2K | |
| 73110 | 286 | 112 | $1K | |
| 73030 | 181 | 72 | $1K | |
| 96116 | 36 | 19 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 194 | 105 | $1K |
| 73140 | 248 | 111 | $904.66 | |
| 36415 | Collection of venous blood by venipuncture | 248 | 172 | $806.54 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 242 | 158 | $778.13 |
| 69209 | 217 | 73 | $767.45 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 675 | 374 | $571.09 |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 16 | 16 | $528.17 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 49 | 28 | $450.23 |
| 72100 | 76 | 29 | $402.10 | |
| 86703 | 38 | 35 | $383.95 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 401 | 207 | $379.44 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 627 | 398 | $345.56 |
| 96136 | 57 | 31 | $329.99 | |
| S9083 | Global fee urgent care centers | 380 | 174 | $233.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 184 | 59 | $164.85 |
| 86308 | 55 | 30 | $57.96 | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 50 | 25 | $36.66 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 61 | 22 | $24.94 |
| 29515 | 57 | 32 | $10.73 | |
| 73080 | 29 | 13 | $0.00 | |
| 99000 | 19 | 16 | $0.00 | |
| 12001 | 33 | 12 | $-18.65 |